Published: December 10, 2025
DocuSign, Inc. (NASDAQ: DOCU) is back in the spotlight after a strong fiscal Q3 2026 earnings beat, a fresh AI investment in Europe, and a sharp share-price swing driven by “conservative” guidance. As of the last close on December 9, 2025, DocuSign stock finished at $69.39, up just over 5% on the day but still down roughly 23% year to date and about 35% below its high from last December. [1]
Despite that drawdown, Wall Street’s 12‑month price targets cluster in the mid‑$80s to low‑$90s, implying double‑digit upside from current levels, while the company leans hard into AI‑powered “Intelligent Agreement Management” (IAM) and international expansion. [2]
This article breaks down the latest DocuSign stock news, Q3 results, AI strategy, analyst forecasts, and the key bull and bear arguments as of December 10, 2025.
DocuSign stock today: price, performance and valuation
DocuSign shares closed at $69.39 on December 9, 2025, after trading between $65.33 and $70.61 during the session. [3]
According to MarketBeat, the company now carries a market capitalization of about $13.9 billion, a price‑to‑earnings (P/E) ratio of 48.5, a PEG ratio of 3.4, and a beta just under 1, reflecting tech‑stock volatility but not extreme swings versus the broader market. [4]
Performance over different time frames highlights why DOCU remains controversial:
- Year to date: Around ‑22% to ‑23%, based on MarketScreener data as of December 9. [5]
- 1‑year total shareholder return: About ‑31%. [6]
- 5‑year total return: Roughly ‑72%, reflecting the long slide from its pandemic‑era peak. [7]
- Drawdown from all‑time high: Shares remain about 78% below their 2021 high, according to a recent Motley Fool analysis. [8]
Simply Wall St notes that DocuSign trades at a P/E in the mid‑40s, above the US software sector average in the low 30s, reinforcing the idea that the stock still embeds meaningful growth expectations despite its big long‑term drawdown. [9]
Q3 fiscal 2026: strong earnings, cautious outlook
DocuSign’s fiscal Q3 2026 (quarter ended October 31, 2025) was objectively solid on almost every line item.
Headline numbers
From DocuSign’s official earnings release: [10]
- Revenue: $818.4 million, up 8% year over year
- Subscription revenue: $801.0 million, up 9% YoY
- Professional services & other: $17.4 million, down 14% YoY
- Billings: $829.5 million, up 10% YoY
- GAAP gross margin: 79.2% (slightly down from 79.3% a year ago)
- Non‑GAAP gross margin: 81.8% (down from 82.5%)
- GAAP EPS (diluted): $0.40 vs. $0.30 a year ago
- Non‑GAAP EPS (diluted): $1.01 vs. $0.90 a year ago
- Operating cash flow: $290.3 million vs. $234.3 million a year ago
- Free cash flow: $262.9 million vs. $210.7 million a year ago
- Share repurchases: $215.1 million in the quarter
IndexBox and other outlets highlighted that net income reached about $83.7 million, with adjusted EPS topping analyst expectations by roughly 10%. [11]
In other words: growth is mid‑single‑digit to high single‑digit, margins are healthy, and cash generation is strong.
Why the stock sold off anyway
So why did DOCU drop 6–7% immediately after the earnings release?
Multiple coverage outlets point to the same culprit: guidance.
DocuSign guided for: [12]
- Q4 FY26 revenue: $825–$829 million (about 7% YoY growth)
- FY26 revenue: $3.208–$3.212 billion (about 8% YoY growth)
- Q4 Billings growth: ~8% YoY at the midpoint
- FY26 non‑GAAP operating margin: just under 30%
While guidance technically beat or matched Wall Street expectations, it did not signal any substantial acceleration in growth. Proactive Investors summarized the market’s reaction: shares fell nearly 7% as the “conservative” outlook overshadowed the earnings beat. [13]
Barchart and Finviz carried similar commentary, noting a 6.6% intraday decline after the company released a cautious financial outlook, despite strong Q3 results. [14]
Invezz and other analysts framed the reaction more bluntly: DocuSign’s growth has stalled relative to its hyper‑growth pandemic phase, and at a premium multiple, even decent numbers plus conservative guidance can hit the stock hard. [15]
AI-first strategy and the Ireland expansion
Beneath the quarterly noise, DocuSign is trying to reinvent itself as an AI‑native agreement platform, not just an e‑signature vendor.
Intelligent Agreement Management (IAM) and Docusign Iris
The company now brands itself as “the Intelligent Agreement Management company,” anchored around its IAM platform, which aims to manage the entire lifecycle of agreements—creation, signing, analysis, and renewal—using AI. [16]
Key elements of this strategy include: [17]
- Docusign IAM platform: AI‑powered tools to create, negotiate, sign, and manage agreements in one unified system.
- Docusign Iris: an AI engine that powers capabilities like AI‑assisted contract review, automated extraction of key terms, obligation management, and analytics.
- Navigator & Maestro:
- Navigator centralizes contracts in a searchable, AI‑driven repository.
- Maestro orchestrates multi‑step agreement workflows across systems like Salesforce and Microsoft Dynamics.
- Integrations with leading AI ecosystems: At its Discover ‘25 developer event, DocuSign announced IAM integrations via its Model Context Protocol server with platforms such as ChatGPT, Anthropic Claude, Google’s Gemini Enterprise, GitHub Copilot, and Microsoft Copilot Studio—an attempt to plug agreement data into the broader AI tooling stack. [18]
Management reports more than 25,000 customers now on the IAM platform, with around 150 million agreements stored in Navigator. [19]
Security and compliance are part of the pitch: in September 2025, the IAM platform earned FedRAMP Moderate authorization, enabling broader use by US government agencies and regulated customers. [20]
New €4.5 million AI investment in Ireland
On December 9, DocuSign announced a €4.5 million investment in Dublin, marking 10 years in Ireland and expanding its AI Centre of Excellence there. [21]
According to the company and Ireland’s IDA:
- The investment will increase engineering headcount by about 20% in Dublin. [22]
- The expanded centre will focus on AI features tailored for European regulatory environments, including identity verification, contract analysis, and data privacy tooling. [23]
- Dublin complements DocuSign’s existing European R&D hub in Paris and supports customers across Europe, the Middle East and Africa. [24]
The move is clearly positioned as both AI‑heavy and EU‑compliance‑friendly, reinforcing DocuSign’s ambition to be the default agreement platform for large enterprises that care about data residency, privacy, and sovereignty.
What Wall Street is saying: ratings, price targets and forecasts
Wall Street is cautious but not bearish on DocuSign.
Consensus ratings and targets
Several data providers paint a similar picture:
- MarketBeat reports 4 Buy ratings and 16 Hold ratings, for a consensus “Hold”, and an average 12‑month price target of $86.71 (high $124, low $70). At the recent price, that implies roughly 25% upside. [25]
- StockAnalysis tracks 14 analysts with a consensus rating of “Hold” and an average price target of $88.14, implying about 27% upside over the next year. [26]
- Public.com likewise notes a Hold consensus and a target around $90.93 among 14 analysts. [27]
Simply Wall St’s fair‑value model pegs intrinsic value at roughly $87.88 per share, framing DOCU as about 25% undervalued relative to earlier closes near $66. [28]
Recent target cuts and neutral stances
While the average target suggests upside, the direction of recent revisions is more cautious:
- Bank of America cut its target from $102 to $82, citing growth concerns but maintaining a neutral rating. [29]
- Evercore ISI lowered its target from $92 to $80, also with an “In‑line” or neutral stance. [30]
- Piper Sandler and Robert W. Baird reduced targets to $75, both neutral. [31]
- A Wedbush note referenced by Nasdaq put the average one‑year target at about $96.58, implying over 35% upside from a prior close around $71, but still carried a Neutral recommendation. [32]
Schaeffers Research summed up the mood around earnings as “Analysts, bears target DocuSign stock despite beat‑and‑raise,” noting elevated options activity and focus on the conservative outlook. [33]
Independent valuation takes
Outside broker research:
- Seeking Alpha authors have described DocuSign as a “value buy” or “cheap SaaS growth play,” emphasizing improving margins, positive net retention and the IAM‑driven upsell opportunity at an EV/revenue multiple under 4x FY27 estimates. [34]
- A Zacks note last month framed the stock’s roughly 24% YTD decline as a potential buying opportunity, given IAM expansion and strengthening margins, but flagged competitive and growth risks. [35]
The overall message: few see DOCU as broken, but many also hesitate to call it a clear bargain given its valuation and slowing revenue growth.
Fundamentals: growth, margins, cash and adoption
Investors trying to decide whether DocuSign is a rebound story or a value trap are primarily watching four levers: growth, profitability, cash generation and platform adoption.
Growth is steady, not explosive
Over the last several quarters, revenue has grown in the high‑single‑digit range:
- Q3 FY25 revenue: $754.8M
- Q4 FY25: $776.3M
- Q1 FY26: $763.7M
- Q2 FY26: $800.6M
- Q3 FY26: $818.4M
Simply Wall St and Webull analysis highlight these steps, with trailing‑twelve‑month EPS around $1.49 and a net margin of roughly 9.6%. [36]
This is respectable but no longer hyper‑growth. DocuSign appears to be transitioning into a mature SaaS company targeting high single‑digit to low double‑digit growth—exactly the kind of profile where valuation and margins matter a lot.
Margins trending upward
Non‑GAAP operating and net margins have been improving as management tightens costs and scales the IAM platform:
- Non‑GAAP gross margin remains a robust ~82%. [37]
- Non‑GAAP operating margin is guided to just under 30% for FY26. [38]
That combination—mid‑teens (or higher) free cash flow margin plus mid‑single‑digit to high‑single‑digit revenue growth—is what draws “value‑in‑disguise” arguments from some analysts.
Cash generation and balance sheet
With $262.9 million in free cash flow this quarter and roughly $1.0 billion in cash and investments on the balance sheet, DocuSign has room to keep investing in R&D and AI while returning capital via buybacks. [39]
The company repurchased over $215 million of stock in Q3 alone and continues to run an active buyback program, which supports EPS growth even if revenue growth remains modest. [40]
Customer and platform adoption
Management emphasizes that the IAM platform is starting to drive larger deals and higher average revenue per customer, as organizations expand from basic e‑signature to workflow, analytics, and AI‑driven contract intelligence. [41]
Important traction markers:
- 25,000+ IAM customers and ~150 million opted‑in agreements in Navigator. [42]
- Multiple language and regional expansions, including Navigator’s rollout in Brazilian Portuguese, Spanish and Japan. [43]
- Repeat recognition as a Leader in Gartner’s CLM Magic Quadrant and inclusion in Fortune’s Future 50 list for long‑term growth prospects. [44]
Ownership, insider moves and institutional positioning
Institutional ownership remains high, with about 77.6% of shares held by institutions and hedge funds, according to MarketBeat. [45]
Recent notable moves:
- Amundi reduced its DOCU stake by 16.9% in Q2, selling roughly 108,954 shares but still holding about 537,157 shares (around 0.27% of the company), worth over $41 million at the time of filing. [46]
- Insiders have sold roughly 104,000 shares over the last 90 days, valued at about $7.8 million—sizeable in dollars but modest relative to total shares outstanding of around 200+ million. [47]
- A separate filing showed director Anna Marrs selling 365 shares on December 2, leaving her with 11,163 shares—a minor trim rather than a large exit. [48]
These moves add nuance but do not, on their own, signal a clear bullish or bearish institutional verdict.
Bear case: why skepticism persists
Despite improving profitability and strong cash flow, several themes fuel ongoing skepticism:
- Slowing top‑line growth
With revenue growing in the high single digits and guidance not signaling a big acceleration, some investors argue that DocuSign no longer deserves a premium SaaS multiple near 45–50x earnings. [49] - Rule‑of‑40 concerns and valuation
Invezz and others flag that, even with solid margins, DocuSign’s growth + margin profile doesn’t scream deep value when compared to faster‑growing SaaS peers. Some models suggest the stock is close to fairly valued if growth slows further. [50] - Competition in e‑signature and contract AI
Adobe, Salesforce, Microsoft and a crop of AI‑native contract startups are all targeting overlapping workflows. That raises questions about how durable DocuSign’s moat is if the IAM transition underdelivers. [51] - Conservative guidance and signaling risk
Multiple commentators highlighted how DocuSign’s cautious Q4 outlook overshadowed its Q3 beat, prompting analysts to cut price targets and traders to sell into strength. [52] - Long, painful drawdown
A five‑year total return of ‑70%+ and a 78% drop from all‑time highs have left many investors wary, even if the underlying business is healthier today than during the peak‑mania years. [53]
Bull case: why some see DOCU as a mispriced compounder
On the other side, bulls argue that the market is underestimating IAM, AI monetization, and margin leverage:
- Platform transition unlocking upsell
As customers move from point‑solution e‑signature to IAM (Navigator, Maestro, Iris and integrations), DocuSign can bundle more capabilities and grow average revenue per account without needing hyper‑aggressive new‑logo growth. [54] - AI and compliance tailwinds
FedRAMP Moderate authorization, deep integrations with leading AI ecosystems, and the Ireland AI Centre of Excellence all position DocuSign as a trusted, compliant AI partner for contracts—a space where regulatory friction can be as important as features. [55] - Healthy cash flow and buybacks
Strong free cash flow and a billion‑dollar cash balance offer resilience and optionality, from acquisitions to continued buybacks that reduce share count over time. [56] - Discount to fair value models and analyst targets
- Improving retention and margin trends
Recent coverage on Seeking Alpha and others highlights better net retention and multi‑year margin expansion, arguing that DOCU’s earnings growth could eventually drive a re‑rating even if revenue growth stays single‑digit. [59]
In short, the bull case sees DocuSign as a maturing SaaS platform where the market is overreacting to modest growth and under‑pricing recurring cash flows and AI‑driven expansion.
What to watch next for DOCU stock
As investors weigh whether DocuSign is a recovery story or a value trap, several catalysts and metrics will matter over the coming quarters:
- Q4 FY26 results and FY27 guidance
Any sign of revenue growth re‑accelerating above the high‑single‑digit band—or, conversely, slipping below guidance—will likely move the stock sharply. [60] - IAM adoption metrics
Watch for updates on IAM customers, contract counts in Navigator, and AI‑driven products like Iris. These give clues as to whether IAM is truly a second growth engine or just a rebranding of e‑signature. [61] - European AI rollout and regulatory wins
The Dublin AI investment is small in dollar terms but strategically important. Evidence that it helps win regulated EU deals or expands AI offerings tailored to GDPR‑heavy environments would be a plus. [62] - Analyst revisions and sentiment shifts
After a wave of target cuts around Q3, any upgrades or target hikes—especially from currently neutral houses—would be a sign that the Street is gaining confidence in DocuSign’s medium‑term trajectory. [63] - Competitive landscape in contract AI
Moves from Adobe, Salesforce, Microsoft, and smaller AI‑contract startups will shape how much pricing power and differentiation DocuSign can maintain. [64]
Bottom line
As of December 10, 2025, DocuSign sits in a classic tug‑of‑war:
- A profitable, cash‑generating SaaS business with high‑80s‑style margin potential, real AI capabilities and a deep enterprise footprint.
- A stock with slower revenue growth, cautious guidance, and a still‑elevated multiple that leaves little room for disappointment.
For investors, DOCU has transitioned from a hyper‑growth momentum name to a fundamentals‑driven, debate‑heavy compounder candidate. Whether it ultimately looks cheap or expensive a few years from now will likely hinge on a single question: can Intelligent Agreement Management and AI meaningfully re‑accelerate growth, or will DocuSign settle into “good but not great” territory?
Either way, this remains a stock where understanding the interplay between growth, margins, AI execution and valuation is more important than watching the next day’s price move.
References
1. stockanalysis.com, 2. www.marketbeat.com, 3. stockanalysis.com, 4. www.marketbeat.com, 5. www.marketscreener.com, 6. simplywall.st, 7. simplywall.st, 8. www.fool.com, 9. simplywall.st, 10. investor.docusign.com, 11. www.indexbox.io, 12. investor.docusign.com, 13. www.proactiveinvestors.co.uk, 14. www.barchart.com, 15. www.tradingview.com, 16. www.docusign.com, 17. investor.docusign.com, 18. investor.docusign.com, 19. investor.docusign.com, 20. community.docusign.com, 21. www.prnewswire.co.uk, 22. www.prnewswire.co.uk, 23. www.prnewswire.co.uk, 24. www.prnewswire.co.uk, 25. www.marketbeat.com, 26. stockanalysis.com, 27. public.com, 28. simplywall.st, 29. www.investing.com, 30. www.investing.com, 31. www.marketbeat.com, 32. www.nasdaq.com, 33. www.schaeffersresearch.com, 34. seekingalpha.com, 35. www.zacks.com, 36. simplywall.st, 37. investor.docusign.com, 38. investor.docusign.com, 39. investor.docusign.com, 40. investor.docusign.com, 41. investor.docusign.com, 42. investor.docusign.com, 43. investor.docusign.com, 44. investor.docusign.com, 45. www.marketbeat.com, 46. www.marketbeat.com, 47. www.marketbeat.com, 48. www.gurufocus.com, 49. www.ainvest.com, 50. www.tradingview.com, 51. www.docusign.com, 52. www.barchart.com, 53. simplywall.st, 54. www.docusign.com, 55. community.docusign.com, 56. investor.docusign.com, 57. simplywall.st, 58. www.marketbeat.com, 59. seekingalpha.com, 60. investor.docusign.com, 61. investor.docusign.com, 62. www.prnewswire.co.uk, 63. www.marketbeat.com, 64. www.docusign.com
